On July 26, Brooklyn announced results from the Phase II INSPIRE trial of IRX-2, a multi-cytokine biological immunotherapy. The trial was designed to evaluate the
In a new study, researchers from Weill Cornell Medical College and Duke University found that antibodies that recruit virus-engulfing white blood cells may protect infants
Dreaming up new proteins, AI churns out possible medicines and vaccines Instead of predicting the shapes of naturally occurring molecules, software designs original ones Science
Coronaviruses are a large group of viruses that exist widely in nature, and they are also the viruses with the largest genome among the known
On January 30, 2020, the British AI pharmaceutical company announced with a high profile that the first molecule designed by artificial intelligence entered Phase I
Recently, Sanofi and Neuraxpharm reached an agreement to sell 17 drugs to Neuraxpharm for an undisclosed amount.The drugs are understood to include two product portfolios
On July 18, Samsung Bio announced that it had officially signed a land purchase agreement with the Incheon Free Economic Zone to support the construction
On July 19, Incyte announced that the FDA approved ruxolitinib cream 1.5% for the topical treatment of non-segmental vitiligo in adults and children over 12
SAN DIEGO–(BUSINESS WIRE)–Jul. 18, 2022– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a New Drug Application (NDA) to the U.S.
Inflammatory myofibroblastic tumor (IMT), also known as plasma cell granuloma, inflammatory pseudotumor, fibrous histiocytoma, fibrous xanthoma, and xanthogranuloma, is a tumor composed of smooth muscle
On July 18, FiercePharma released the 2021 TOP10 list of global generic drug giants. The global sales of generic drugs in 2021 is unknown, but
Endo Moving Toward Bankruptcy Filing Without Opioid Settlement Deal WSJ Endo is considering filing for bankruptcy protection to get rid of a massive $8 billion
